Dr. Collin Hovinga will lead two public-private partnerships at C-Path — the Rare Disease Cures Accelerator Data and Analytics Platform (RDCA-DAP®) and the Critical Path for Rare Neurodegenerative Diseases (CP-RND).Continue reading
Category Archives: AZBio News
UArizona researchers develop ‘Goldilocks drug’ to treat triple-negative breast cancer
University of Arizona researchers have been working for decades to develop a drug that so specifically targets a deadly kind of breast cancer that there are little to no toxic side effects.Continue reading
NeoLight acquires first-of-its-kind musical pacifier technology for premature babies
SCOTTSDALE, Ariz., Oct. 25, 2022 /PRNewswire/ — NeoLight has signed an agreement to acquire the Pacifier Activated Lullaby (PAL®) System by Powers Medical Inc., a US-based medical technology company that focuses on musical therapy in the newborn baby market. This acquisition strengthens the NeoLight neonatal portfolio by introducing a solution for two growing concerns in newborn care; Non-nutritive sucking (NNS) and Neonatal Abstinence Syndrome (drug-addicted babies).Continue reading
Aesthetics Biomedical ® Inc. Announces FDA Clearance of Vivace Ultra™, The First-and-Only Personalized Radiofrequency (RF) Microneedling Technology
Revolutionizing treatments with unmatched precision and visionContinue reading
ASU researcher advances the science of protein sequencing with NIH Innovator Award
Chao Wang, a researcher with the Biodesign Center for Molecular Design and Biomimetics at Arizona State University, and his colleagues are advancing an ambitious project: developing new methods for sequencing individual protein molecules using a rapid, accurate and inexpensive methodContinue reading
C-Path and Sturge-Weber Foundation Announce Data Sharing Agreement to Support Treatment Development for Sturge-Weber Syndrome
TUCSON, Ariz., October 20, 2022 — Critical Path Institute (C-Path) and the Sturge-Weber Foundation today announced a joint collaboration to incorporate patient data for Sturge-Weber syndrome (SWS) into C-Path’s Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP®).Continue reading
C-Path’s Ramona Walls Promoted to Executive Director of Data Science
TUCSON, Ariz., October 20, 2022 — Critical Path Institute (C-Path) has named Ramona L. Walls, Ph.D., as Executive Director of Data Science within C-Path’s Data Collaboration Center (DCC).Continue reading
The IRA is now law. What comes next?
AZBio President & CEO, Joan Koerber-Walker provides a brief overview of the provision of the Inflation Reduction act of 2022 (The IRA) from the patient and health innovation perspective and is then joined by health innovator and drug developer, Dr. Steven J. Potts, for a discussion of the potential unintended consequences of some provisions of The IRA relating to the future health innovation landscape.Continue reading
The Tissue Reference Group at the FDA, Recognizes BioLab Sciences Membrane Wrap – Hydro™ as an HCT/P
The unique amniotic membrane allograft aids in the covering and protection of wounds
Dr. Curiel-Lewandrowski Accepted into Leadership Fellowship
Clara Curiel-Lewandrowski, MD, FAAD, professor of medicine and chief of the Division of Dermatology in the UArizona College of Medicine – Tucson has been accepted into the Hedwig van Ameringen Executive Leadership in Academic Medicine (ELAM) program.Continue reading